Tuesday, November 19, 2024
HomeTags$6 Million

$6 Million

BioFluidica Announces $6 Million Series B2 Funding to Support of its Liquid Biopsy Microfluidics Platform.

BioFluidica, Inc., a biotechnology company developing a diagnostic platform allowing for disease management and diagnosis, today announced that it has raised over $6 million...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics